Boryung

(주)보령 · KOSPI · 003850 · Industry: Manufacture of medicaments

Key metrics

Earnings

Revenue, Q3 2026₩314.4bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ+12.4% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoY+12.3% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income, Q3 2026₩25.5bn As of Sep 30, 2026 Source 1 ↗
Operating income QoQ+7.1% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoY-13.4% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗

Share buybacks

Buyback decided, last 3 months₩0 As of Nov 19, 2026
Buyback decided, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 3 months₩20.0bn As of Sep 11, 2026 Source 1 ↗
Shares acquired, last 3 months, % of shares2.7% As of Sep 11, 2026 Source 1 ↗, Source 2 ↗
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Buyback decided, last 12 months₩20.0bn As of Jun 12, 2026 Source 1 ↗
Buyback decided, last 12 months, % of shares2.8% As of Jun 12, 2026 Source 1 ↗, Source 2 ↗
Shares acquired, last 12 months₩20.0bn As of Sep 11, 2026 Source 1 ↗
Shares acquired, last 12 months, % of shares2.7% As of Sep 11, 2026 Source 1 ↗, Source 2 ↗
Treasury shares cancelled, last 12 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 12 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩0 As of Nov 19, 2026
Rights offering new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Supply contracts

Supply contracts, last 12 months₩383.7bn As of Sep 22, 2026 Source 1 ↗
Supply contracts vs prior-year revenue37.7% As of Sep 22, 2026 Source 1 ↗
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months16 As of Nov 19, 2026
DART filings, previous 3 months10 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market buys, last 12 months (amount)₩0 As of Nov 19, 2026
Open-market sells, last 12 months (shares)7,000 shares As of Feb 10, 2026 Source 1 ↗
Open-market sells, last 12 months (amount)₩64m As of Feb 10, 2026 Source 1 ↗
Net open-market buying, last 12 months (shares)-7,000 shares As of Feb 10, 2026 Source 1 ↗
Insiders who bought, last 12 months0 As of Nov 19, 2026

Insider transactions (last 12 months)

Open-market buys: 0 shares (₩0). Open-market sells: 7,000 shares (₩64m). Net open-market buying: -7,000 shares. Insiders who bought: 0.

Trade dateInsider (role)TypeSharesPriceAmount
May 1, 2026Bo Ryeong-hol-ding-seu Co., Ltd. (10%+ shareholder)Other (Merger in)+18,097,207 shares——
May 1, 2026Boryeongpateuneoseu Co., Ltd. (10%+ shareholder)Other (Merger out)-18,097,207 shares——
Feb 10, 2026Lee Geun-jae (Non-registered officer)Open-market sell-6,245 shares₩9,090₩57m
Feb 10, 2026Lee Geun-jae (Non-registered officer)Open-market sell-755 shares₩9,100₩7m

Annual financials

YearRevenueOperating income
2025₩1.0tn₩65.1bn
2024₩1.0tn₩70.5bn
2023₩859.6bn₩68.3bn

Filing timeline